DK1644739T3 - Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner - Google Patents

Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner

Info

Publication number
DK1644739T3
DK1644739T3 DK04767522T DK04767522T DK1644739T3 DK 1644739 T3 DK1644739 T3 DK 1644739T3 DK 04767522 T DK04767522 T DK 04767522T DK 04767522 T DK04767522 T DK 04767522T DK 1644739 T3 DK1644739 T3 DK 1644739T3
Authority
DK
Denmark
Prior art keywords
cell
detecting
event
binding
solubilization
Prior art date
Application number
DK04767522T
Other languages
Danish (da)
English (en)
Inventor
Francois Ichas
Giorgi Ichas Francesca De
Pier-Vincenzo Piazza
Jean Dessolin
Laura Schembri
Flora Tomasello
Lydia Lartigue
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1644739T3 publication Critical patent/DK1644739T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DK04767522T 2003-07-04 2004-06-30 Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner DK1644739T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308186A FR2857098B1 (fr) 2003-07-04 2003-07-04 Procede de mise en evidence d'un evenement moleculaire dans une cellule grace a des proteines marqueurs fluorescentes.
PCT/FR2004/001678 WO2005012913A2 (fr) 2003-07-04 2004-06-30 Procede de mise en evidence d'un evenement moleculaire dans une cellule grace a des proteines marqueurs fluorescentes

Publications (1)

Publication Number Publication Date
DK1644739T3 true DK1644739T3 (da) 2008-08-25

Family

ID=33522767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04767522T DK1644739T3 (da) 2003-07-04 2004-06-30 Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner

Country Status (10)

Country Link
US (2) US20070042445A1 (ja)
EP (1) EP1644739B1 (ja)
JP (2) JP4864702B2 (ja)
AT (1) ATE393392T1 (ja)
CA (1) CA2531225A1 (ja)
DE (1) DE602004013320T2 (ja)
DK (1) DK1644739T3 (ja)
ES (1) ES2305837T3 (ja)
FR (1) FR2857098B1 (ja)
WO (1) WO2005012913A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096886B2 (en) * 2011-03-11 2015-08-04 Merz Pharma Gmbh & Co. Kgaa Method for the determination of botulinum neurotoxin biological activity
WO2018235251A1 (ja) * 2017-06-23 2018-12-27 株式会社ニコン 解析装置、解析プログラム及び解析方法
CN109251492B (zh) * 2017-07-13 2022-10-28 新加坡国立大学 生物墨水及其制备方法和应用
CN111272518B (zh) * 2020-01-16 2022-07-01 南方医科大学南方医院 一种荧光探针及其在细胞染色中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618794B2 (fr) * 1987-02-16 1991-03-15 Agronomique Inst Nat Rech Vecteur de clonage du gene de structure de la nitrate reductase et sonde d'adn obtenue
GB9301553D0 (en) * 1993-01-27 1993-03-17 Univ Wales Protein synthesis
EP1500702A1 (en) * 1996-04-01 2005-01-26 Genentech, Inc. APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy
AU6440798A (en) * 1997-02-26 1998-09-18 Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulation of vesicular release
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6828106B2 (en) * 1999-02-26 2004-12-07 Cyclacel Limited Methods and compositions using coiled binding partners
EP1185644A1 (en) * 1999-05-27 2002-03-13 Merck Frosst Canada & Co. Assays for caspase activity using green fluorescent proteins
US6110691A (en) * 2000-01-06 2000-08-29 Board Of Regents, The University Of Texas System Activators of caspases
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
JP2004507225A (ja) * 2000-06-01 2004-03-11 インサイト・ゲノミックス・インコーポレイテッド アポトーシス調節因子
GB0111146D0 (en) * 2001-05-04 2001-06-27 Imp College Innovations Ltd Methods
US6979530B2 (en) * 2001-05-21 2005-12-27 Applera Corporation Peptide conjugates and fluorescence detection methods for intracellular caspase assay
EP1478772A2 (en) * 2001-08-14 2004-11-24 The General Hospital Corporation Nucleic acid and amino acid sequences involved in pain
AU2002336517B2 (en) * 2001-09-13 2008-09-11 California Institute Of Technology Method for producing transgenic animals
WO2003044482A2 (en) * 2001-11-16 2003-05-30 The University Of Tennessee Research Corporation Recombinant antibody fusion proteins and methods for detection of apoptotic cells

Also Published As

Publication number Publication date
WO2005012913A3 (fr) 2005-04-21
ATE393392T1 (de) 2008-05-15
JP4864702B2 (ja) 2012-02-01
EP1644739A2 (fr) 2006-04-12
DE602004013320D1 (de) 2008-06-05
DE602004013320T2 (de) 2009-05-14
US20070042445A1 (en) 2007-02-22
WO2005012913A2 (fr) 2005-02-10
FR2857098B1 (fr) 2006-05-05
JP2011135885A (ja) 2011-07-14
ES2305837T3 (es) 2008-11-01
EP1644739B1 (fr) 2008-04-23
JP2007515929A (ja) 2007-06-21
US20120040389A1 (en) 2012-02-16
CA2531225A1 (fr) 2005-02-10
FR2857098A1 (fr) 2005-01-07

Similar Documents

Publication Publication Date Title
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
BRPI0417903A (pt) método de melhorar a detecção de sinal de um componente de parede celular de células
BRPI0515079A (pt) marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados
BRPI0705622A (pt) dispositivo de rele e correspondente método
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
WO2006007403A3 (en) Methods for identifying and measuring s-nitrosothiol bonds in heme-containing cells and molecules
DE60135839D1 (de) Nachweis von analyten
DK1410014T3 (da) Fremgangsmåde til identifikation af pröver fra et pattedyr samt kit til udövelse af fremgangsmåden
WO2006053251A3 (en) Method of measuring amyloid-beta peptides
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
DK1644739T3 (da) Fremgangsmåde til påvisning af en molekylær begivenhed i en celle ved anvendelse af fluorescerende markörproteiner
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
ATE546731T1 (de) Schnelles homogenes immunoassay unter verwendung von elektrophorese
FR2920882B1 (fr) Procede de caracterisation des conditions d'utilisation d'un composant electronique permettant de limiter sa sensibilite aux interactions energetiques
ATE406461T1 (de) Rna-bioassay
WO2002038799A3 (en) Detection of proteases and screening for protease inhibitors
WO2006089801A3 (de) Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide
TW200512459A (en) Global analysis for protein expression kit and protein qualitative and quantitative method thereof
ATE511092T1 (de) Direkter nachweis von molekülen in polyacrylamidgel
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
Zinellu et al. Distribution of low‐density lipoprotein‐bound low‐molecular‐weight thiols: A new analytical approach
ATE446512T1 (de) Doppeltes hybridsystem auf der basis von gen- silencing durch transkriptionelle interferenz
DK1382691T3 (da) Fremgangsmåde til isolering af 20S-proteasomet samt fremgangsmåde til identifikation af inhibitorer af 20S- og 26S-proteasomet
SE0201392D0 (sv) Fusion polypeptide, use thereof and methods employing it
DK1799844T3 (da) Fremgangsmåde til påvisning af mål